The Oxford Parkinson's Disease Centre (OPDC) is a unique multidisciplinary research program at the University of Oxford supported by Parkinson’s UK with funding from The Monument Trust, one of the Sainsbury Family Charitable Trusts until 2021.

Established in February 2010, the OPDC brings together internationally-renowned scientists who work on the genetics of Parkinson’s, the generation of cell and animal models, and the wiring of brain circuits which control movement, with clinical experts in the diagnosis and treatment of Parkinson’s.

Our world-class research centre works to understand the earliest events in the development of Parkinson’s with an ultimate view to target the molecular mechanisms of disease with neuroprotective therapies to prevent disease onset or delay progression.

Our program is focused on the molecular pathways to Parkinson’s in order to:

1. Understand the progression of Parkinson’s
2. Predict the onset of Parkinson’s
3. Identify potential drug targets for Parkinson’s
4. Develop new treatments that will prevent the development of Parkinson’s in at-risk individuals.

Watch the video below to learn more about OPDC's research: